Gerard C. Blobe, MD, PhD Gerard C. Blobe, MD, PhD

Gerard C. Blobe, MD, PhD

Medical Oncologist

4.93 out of 5  (99 ratings, 12 reviews)
Duke Health Provider question Circle Img
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Below are the plans currently accepted in 2018. There are some changes to the plans accepted beginning January 1, 2019. For a complete list of plans accepted in 2019 and to verify that your health plan includes Duke Health, please visit PlanForDuke.com.

Click to see a list of accepted insurance plansHide accepted insurance plans
Contact
919-681-6906, 919-613-5228
Fax number
919-668-6688 Appointments
919-681-6906, 919-613-5228 Fax number
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Below are the plans currently accepted in 2018. There are some changes to the plans accepted beginning January 1, 2019. For a complete list of plans accepted in 2019 and to verify that your health plan includes Duke Health, please visit PlanForDuke.com.

Click to see a list of accepted insurance plansHide accepted insurance plans

Contact
919-681-6906, 919-613-5228 Fax number
WHERE I PROVIDE CARE
Profile
ABOUT ME

I specialize in patients with gastrointestinal diseases with a special emphasis on colorectal and pancreatic cancer. Duke is a special place because of its compassionate clinicians and multidisciplinary care. Working in the same building with our colleagues in surgical and radiation oncology allows us to offer a holistic approach to cancer care. At the same time, we’re doing research on many of the cancers we’re seeing to try to move the field forward, and that gives patients access to clinical trials that are at the cutting-edge. When I see a patient with cancer, I know they are dealing with a major change in their life, and I know it’s very scary for them. I look at every patient I see as someone who could be my mother or my brother or my child. I take that responsibility very seriously. I love interacting with patients and getting to know them not just as patients but as families and members of our community.

LANGUAGES I SPEAK
English
LEARN MORE ABOUT ME
Training
EDUCATION
MD, Duke University School of Medicine, 1995
RESIDENCY
Internal Medicine, Brigham and Women's Hospital (Massachusetts), 1995-1997
Medical Oncology, Dana Farber Cancer Institute (Massachusetts), 1997-2000
BOARD CERTIFICATION
American Board of Internal Medicine, Medical Oncology
American Board of Internal Medicine, Internal Medicine
Clinical Focus and Research
MY RESEARCH INTERESTS

I investigate a signaling pathway, called the transforming growth factor-beta pathway, that controls the growth and survival of cancer cells. We have identified components of this pathway that are altered in human cancers, and how these changes make cancer cells more aggressive. By understanding how this pathway works and how cancer cells become resistant to its effects, we can more effectively target this pathway for the treatment of the cancers that I see.

PUBLICATIONS
View Gerard Blobe's publications on PubMed
Ratings and Reviews

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more about our survey process. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Overall provider rating
4.93 out of 5 (99 ratings, 12 reviews)
PATIENT REVIEWS
Patient comments are gathered from our Press Ganey Patient Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
Industry Relationships and Collaborations
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
  • Genentech, Inc (Roche Holding)
  • Rheomics, Inc.